Sold: 0 items

Japan Mochida Dotinurad Tablets 0.5mg, 1mg, 2mg: 100 tablets (10 tablets × 10) Dotinurad Tablets—Gout Medicine, Cures High Uric Acid, Lowers Uric Acid

1
SKU: N/A
HKD$480.00 – HKD$1,189.00Price range: HKD$480.00 through HKD$1,189.00
In Stock
WhatsApp Product Inquiry
Add to wishlist
Compare
Free shipping on orders over HKD $500, USD $200, or CNY ¥500.
Delivery within 4–7 business days.
Money Back Guarantee
No shipping on Sat, Sun & Japanese national holidays.
Tag: Brand:

描述

Direct overseas shipping (Direct shipping from Japan)

Dotinole Yulis Tablets
URECE® Tablets
0.5 mg / 1 mg / 2 mg

Package Insert No. 3949005F1022_2_01 | Company Code 790005
Revised in December 2024 (6th Edition) / Revised in June 2026 (7th Edition)

Treatment for Hyperuricemia | Dotinurad | Gout and Hyperuricemia

Dotinurad Yuris Tablets for Gout

Product Details / Approvals, etc.

Japan Standard Commodity Classification Code 873949
Pharmacological Classification Name Selective uric acid reabsorption inhibitors
Medications for Hyperuricemia
General Name Dochinurad
Dotinurad
0.5 mg Uris Tablets 0.5 mg / URECE Tablets 0.5 mg
YJ 3949005F1022
Approval 30200AMX00020000
Sales Begin May 2020
1 mg Uris Tablets 1 mg / URECE Tablets 1 mg
YJ 3949005F2029
Approved 30200AMX00021000
Sales Begin May 2020
2 mg Uris Tablets 2 mg / URECE Tablets 2 mg
YJ 3949005F3025
Approved 30200AMX00022000
Sales Begin May 2020
Storage Instructions / Expiration Date Store at room temperature / 3 years
Regulatory Classification –
Manufacturing and Sales Yuan Mochida Pharmaceutical Co., Ltd.
1-7 Yotsuya, Shinjuku Ward, Tokyo
Packaging 0.5/1 mg: 100 tablets, 500 tablets; 2 mg: 100 tablets
Shipping method Direct overseas shipping (Direct shipping from Japan)
Preparation and shipping time After verifying payment and prescription eligibility,
Orders are typically shipped within 4 to 7 business days.

1. Conditions for Recognition

A drug risk management plan must be developed and properly implemented.

2. Product Characteristics and Mechanism of Action (18.)

Dochinulad selectively inhibits URAT1, a renal uric acid reabsorption transporter (IC50 0.0372 μmol/L), promotes the excretion of uric acid via glomerular filtration, and lowers blood uric acid levels. It has low selectivity for BCRP, OAT1, and OAT3.

3. Specifications and Properties (3.2)

Sizes: 0.5 mg, 1 mg, 2 mg
Color: White to pale yellowish-white; White to pale yellowish-white; Very pale red
Identification: FY321/0.5, FY322 (single-sided cut line), FY323/2 (single-sided cut line)
Diameter/Thickness/Weight: Approx. 6.5/2.8 mm/100 mg; Approx. 8.0/3.8 mm/200 mg; Approx. 8.0/3.8 mm/200 m

4. Ingredient Information (3.1/19.)

Each tablet contains 0.5, 1, or 2 mg of dotinurad. The 2 mg tablet contains iron(III) oxide.

19. Molecular formula C14H9Cl2NO4S Molecular weight 358.20; melting point approximately 214°C.

Structural Formula

5. Indications and Usage (4./5.)

Gout, hyperuricemia. When appropriate, patients should be selected based on the specific type of the disease and the latest treatment guidelines.

6. Dosage and Administration (6./7.)

For adults, treatment with dotinurad is typically initiated at 0.5 mg once daily by mouth. The dose should be gradually increased after confirming serum uric acid levels. The maintenance dose is usually 2 mg once daily, which may be adjusted based on the patient’s condition, up to a maximum of 4 mg once daily.

A sudden drop in uric acid levels early in treatment may trigger gouty arthritis; therefore, treatment should begin with a dose of 0.5 mg, followed by gradual increases to 1 mg after 2 weeks and 2 mg after 6 weeks, with careful monitoring required after each dose increase.

7. Precautions and Contraindications (2., 8., 9.)

2. Contraindications Individuals who are allergic to any of the ingredients in this product.

Do not initiate treatment during an attack; if an attack occurs while treatment is underway, do not adjust the dose. Colchicine, NSAIDs, or steroids may be used concomitantly. At the start of treatment, uric acid excretion increases; acidic urine may lead to stone formation, so fluid intake should be increased and urine alkalized. Liver function tests should be performed regularly.

As a general rule, this medication should not be administered to patients with urinary tract stones. In cases of severe renal impairment (eGFR < 30), consider alternative medications; avoid use in patients with oliguria or anuria. Administer to pregnant women only when the benefits outweigh the risks.

Plasma Concentration Reference:

PK

22–26. Other Official Information

22. 0.5 mg: 100/500 tablets; 1 mg: 100/500 tablets (including bulk); 2 mg: 100 tablets

24. Mochida Pharmaceutical Co., Ltd. Medication Consultation Hotline: Tel. 03-5229-3906 / 0120-189-522; Fax: 03-5229-3955

26. Manufacturer and Distributor: Mochida Pharmaceutical Co., Ltd., 1-7 Yotsuya, Shinjuku-ku, Tokyo

※ This page was translated by Hkeemall based on PMDA Package Insert 3949005F1022_2_01. It is not a substitute for a doctor’s prescription or the original Japanese version.
Enter "Yulis" in the PMDA "Package Insert Information" field to search for the original version.

[Disclaimer]

  1. The information regarding medications, treatments, or health management contained in this article is compiled from international authoritative medical journals and official clinical literature, and is intended for general science and educational reference only.
  2. The indications, side effects, and contraindications of related medications may vary depending on national regulations and individual physical conditions. Do not blindly take medication on your own or change your treatment plan.
  3. The author and publishing platform assume no legal liability for any medical delays, adverse reactions, or direct or indirect losses caused by the use of the information in this article. All medical decisions should be discussed with your attending physician before being made.

Additional information

Specifications

Mochida Dotinore Uris Tablets 0.5 mg, Mochida Dotinore Uris Tablets 1 mg, Mochida Dotinore Uris Tablets 2 mg

1 review for 日本持田 多替諾雷 ドチヌラド錠 0.5mg 1mg 2mg:100錠(10錠×10) Dotinurad Tablets 痛風藥 高尿酸治愈 降尿酸

4.00

Average of 1 review

  1. Lai Ming Tong –

    My uric acid levels dropped quickly, and the joint pain has reduced a lot. Mochida's medicine really helps, and I feel completely relieved after taking it!

Add a review

Your email address will not be published. 必填欄位標示為 *

You may also like…

Add to wishlist
4.00

Teijin (Japan) Feburic / Febuxostat (Febuxostat) Feburic Tablets 10 mg, 20 mg, 40 mg Teijin Gout Medicine Treatment for High Uric Acid: 100 tablets

HKD$320.00 HKD$848.00Price range: HKD$320.00 through HKD$848.00
Select options This product has multiple variants. The options may be chosen on the product page
Store
Search
Wishes
cart
Track
Account
Select currency

No products in the cart.

Copyright 2026 © Hkeemall. All rights reserved. |  Return and Exchange Policy  |  Privacy Policy  |  Contact us